SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2052Does this mean much? A 0.7 log reduction translates to a five-fold reduction. A.J. Mullen-11/1/2004
2051>>WILMINGTON, Del.--(BUSINESS WIRE)--Nov. 1, 2004--Incyte Corporation (Nastuck-11/1/2004
2050Results of Phase IIa Study Show That Reverset Has Potential to Reduce HIV Viral nigel bates-10/31/2004
2049<I> marketing strategy for Reverset -- whether or not they intended to go software salesperson-10/23/2004
2048I'm not sure that INCY has talked about their marketing strategy for Reversetuck-10/22/2004
2047Does it make any sense to think that Gild may consider partnering with Incyte noewolf-10/22/2004
2046I'm surprised that the price has almost doubled since August. The reported A.J. Mullen-10/8/2004
2045INCY up 1.47% after announcing the filing of a $175m shelf. That's a good skeokalani'nui-10/8/2004
2044[Potent antiviral effect of reverset in HIV-1-infected adults following a singletuck-10/3/2004
2043[Anti CCR2 for cardiovascular disease?] >>Published online before print Jtuck-8/20/2004
2042Sales, thanks for the 8/04 CC notes. I listened to it a few days thereafter andBiotech Jim-8/18/2004
20418/4/04 conference call notes 1. business review R - - 7/12 results: 4th arm ofsoftware salesperson-8/4/2004
2040>>BANGKOK, Thailand--(BUSINESS WIRE)--July 12, 2004--Incyte Corporation (Ntuck-7/12/2004
2039Yeah - those do seem to be misplaced bets. But most biotech investors have a fewBiomaven-7/9/2004
2038I don't know how they do with the nonreported <5% trades, but their big brkrw-7/9/2004
2037Yes, Baker brothers are well-known and astute biotech investors. PeterBiomaven-7/9/2004
203613-d filed: Any one hear of these guys--Baker Biotech Fund I/II. Some link to quidditch-7/9/2004
2035[High level expression, activation, and antagonism of CC chemokine receptors CCRtuck-6/23/2004
2034Here's a snippet about Pfizer's anti-CCR5 molecule, from last fall'stuck-5/13/2004
2033I believe these are more complete results for Reverset PI than we've seen betuck-5/13/2004
2032Since there's not much going on out there, thought I'd just post the urlquidditch-5/11/2004
2031Thanks ! (As always.) Looks as though there won't be much newsflow for a fenigel bates-5/4/2004
20305/4/04 cc notes 1. 1st q update raised 250 m ; closing palo alto; R - - p 2software salesperson-5/4/2004
2029Incyte Announces First Quarter 2004 Financial Results, Provides Update on Most Anigel bates-5/4/2004
2028A belated thank you to Biomaven and Richard for the clarification regarding CCR2microcapfun-3/28/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News